 |
|
Mayo Clinic study unveils unprecedented method to predict ALS, Parkinson's disease
January 16, 2008ROCHESTER, Minn. -- A new Mayo Clinic study details an unprecedented method to predict brain aging disorders such as amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) and Parkinson's disease. Investigators studied common variations within axon guidance pathway genes and identified several gene variations (DNA fingerprints) that collectively predicted people who are at a high risk for ALS (2,000 times greater than the average risk). They also identified several gene variations that collectively predicted people at a high risk for Parkinson's disease (nearly 400 times greater than the average risk).
The probability that the findings were by chance was extremely small (less than one in a trillion). The axon guidance pathway consists of a complex array of chemical signals that wires the brain during fetal development and maintains and repairs brain wiring throughout life. The study is published online in the public access journal PLoS ONE. (www.plosone.org/home.action)
"The mission of our research is to predict, prevent and halt brain aging disorders," explains Demetrius Maraganore, M.D., Mayo Clinic neurologist and principal investigator. "I envision a day when we will be able to do a simple blood test and predict whether a person is at high risk to develop brain aging disorders such as ALS, Parkinson's disease and even Alzheimer's disease by studying common gene variations in disease pathways. In persons at high risk, we may be able to prevent the diseases or slow or halt their progression by developing drugs that target the same disease pathways. For ALS and Parkinson's disease, our study is a major step in these directions."
About the Study
In June 2007, the investigators reported similar findings for Parkinson's disease. However, with this new study they extended their findings to ALS, where they observed greater effects. The investigators noted that while up to 50 percent of the axon guidance pathway genes that predict ALS or Parkinson's disease are in common, there also are gene variations that are specific to either disease. This may help explain the similarities and differences that are seen in persons with these diseases, or the clustering of such diseases that sometimes occur within isolated populations or families.
The investigators obtained these results by analyzing publicly available datasets of whole-genome variations in people with ALS, Parkinson's disease and those who did not have neurological disorders. The datasets were released recently by the Coriell Institute and the National Institutes of Health. The investigators developed and applied to the data a genomic pathways approach.
"The size of the effects that were observed and their statistical significance are unprecedented in the study of brain aging disorders. I attribute our success to the genomic pathways approach we developed," adds Timothy Lesnick, Mayo Clinic biostatistician. "Now we need to develop a better map of the gene variations within the axon guidance pathway and make comparisons across multiple brain aging diseases and populations."
ALS causes degeneration of the nerve cells in certain regions of the brain and spinal cord that control a person's voluntary muscles. Eric Sorenson, M.D., and Eric Ahlskog, M.D., Ph.D., Mayo Clinic neurologists specializing in ALS and movement disorders, agree that impairments in brain wiring and repair are plausible causes of ALS and Parkinson's disease. Investigators agree that additional research is needed to continue the success obtained in this study.
"I envision experiments in cultured cells and animal models to define the most important treatment targets within the axon guidance pathway," says John Henley, Ph.D., Mayo Clinic neuroscientist and expert on brain wiring and repair processes.
Mayo Clinic
About the Study
In June 2007, the investigators reported similar findings for Parkinson's disease. However, with this new study they extended their findings to ALS, where they observed greater effects. The investigators noted that while up to 50 percent of the axon guidance pathway genes that predict ALS or Parkinson's disease are in common, there also are gene variations that are specific to either disease. This may help explain the similarities and differences that are seen in persons with these diseases, or the clustering of such diseases that sometimes occur within isolated populations or families.
The investigators obtained these results by analyzing publicly available datasets of whole-genome variations in people with ALS, Parkinson's disease and those who did not have neurological disorders. The datasets were released recently by the Coriell Institute and the National Institutes of Health. The investigators developed and applied to the data a genomic pathways approach.
"The size of the effects that were observed and their statistical significance are unprecedented in the study of brain aging disorders. I attribute our success to the genomic pathways approach we developed," adds Timothy Lesnick, Mayo Clinic biostatistician. "Now we need to develop a better map of the gene variations within the axon guidance pathway and make comparisons across multiple brain aging diseases and populations."
ALS causes degeneration of the nerve cells in certain regions of the brain and spinal cord that control a person's voluntary muscles. Eric Sorenson, M.D., and Eric Ahlskog, M.D., Ph.D., Mayo Clinic neurologists specializing in ALS and movement disorders, agree that impairments in brain wiring and repair are plausible causes of ALS and Parkinson's disease. Investigators agree that additional research is needed to continue the success obtained in this study.
"I envision experiments in cultured cells and animal models to define the most important treatment targets within the axon guidance pathway," says John Henley, Ph.D., Mayo Clinic neuroscientist and expert on brain wiring and repair processes.
Mayo Clinic
Amyotrophic Lateral Sclerosis Current Events and Amyotrophic Lateral Sclerosis News RSSSchizophrenia gene's role may be broader, more potent, than thought
UCSF scientists studying nerve cells in fruit flies have uncovered a new function for a gene whose human equivalent may play a critical role in schizophrenia.
Compound shows potential for slowing progression of ALS
A chemical cousin of a drug currently used to treat sepsis dramatically slows the progression of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, in mice.
New guidelines identify best treatments to help ALS patients live longer, easier
New guidelines from the American Academy of Neurology identify the most effective treatments for amyotrophic lateral sclerosis (ALS), often called Lou Gehrig's disease. The guidelines are published in the October 13, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology.
Scientists encouraged by new mouse model's similarities to human ALS
A new mouse model of amyotrophic lateral sclerosis (ALS) closely resembles humans with the paralyzing disorder, researchers at Washington University School of Medicine in St. Louis report.
Amyotrophic lateral sclerosis may involve a form of sudden, rapid aging of the immune system
Premature aging of the immune system appears to play a role in the development of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to research scientists from the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center, the Weizmann Institute of Science in Israel, and Sheba Medical Center in Israel.
Physician-assisted suicide does not increase severity of depression, grief among family members
Unlike other forms of suicide, physician assisted death does not cause substantial regret, or a sense of rejection among surviving family members.
Mechanism related to the onset of various genetic diseases revealed
Researchers at the Department of Biochemistry and Molecular Biology of Universitat Autònoma de Barcelona (UAB) have revealed the process by which proteins with a tendency to cause conformational diseases such as amyotrophic lateral sclerosis, familial amyloidotic polyneuropathy, familial amyloidotic cardiomyopathy, etc. finally end up causing them.
Michigan Tech Mathematicians Identify Genes Linked to Lou Gehrig's Disease
Michigan Technological University researchers have linked three genes to the most common type of amyotrophic lateral sclerosis (ALS), generally known as Lou Gehrig's disease.
New Jefferson study may redefine how a chronic auto-immune disease is diagnosed
New research from Jefferson Hospital for Neuroscience (JHN) may redefine how Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is diagnosed.
Fatal brain disease at work well before symptoms appear
University of Florida scientists have discovered why a paralyzing brain disorder speeds along more rapidly in some patients than others - a finding that may finally give researchers an entry point toward an effective treatment for amyotrophic lateral sclerosis, often referred to as ALS or Lou Gehrig's disease.
More Amyotrophic Lateral Sclerosis Current Events and Amyotrophic Lateral Sclerosis News Articles
 |
Amyotrophic Lateral Sclerosis: A Guide for Patients and Families by M.D. Hiroshi Mitsumoto (Editor) This important book covers every aspect of living with ALS, from clinical features of the disease to an overview of symptom management to understanding its diagnosis. Major sections deal with overseeing medical care and rehabilitation, living with ALS, the disease’s advanced phase, end-of-life issues, and resources. Extensively revised and rewritten, this edition contains new chapters on the latest approaches to treating ALS symptoms, the use of noninvasive ventilators, multidisciplinary team care, new guidelines being developed by the American Academy of Neurology for patients with ALS, the use of riluzole (Rilutek), and more. |
 |
Amyotrophic Lateral Sclerosis (American Academy of Neurology) by M.D. Robert G. Miller (Author), M.D. Deborah Gelinas (Author), RN Patricia O'Connor (Author) ALS, also known as Lou Gehrig's disease, cannot be cured, but treatments are now available that can make a major difference in prolonging and enhancing life. Written by clinicians who manage one of the leading ALS centers in the world, this book guides readers through an understanding what ALS is, how it is diagnosed, the management of symptoms, and the drugs that are available to treat the underlying disease process. Chapters cover topics that include nutrition and swallowing; speech, communication, and computer access; mobility; breathing and sleeping; end-of-life care; and much more, including insurance issues and practical tips. Chapters from leading ALS organizations offer a broad list of support services, publications, websites, and other resources. |
 |
Amyotrophic Lateral Sclerosis Awareness Ribbon Mouse Pad by MyHeritageWear.com The Amyotrophic Lateral Sclerosis proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Amyotrophic Lateral Sclerosis than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Amyotrophic Lateral Sclerosis mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness! |
|
Ecological Formulas Sphingolin Caps 60's (Use of This Product May Benefit Those with Myelin Diseases Such As Multiple Sclerosis (Ms) and Amyotrophic Lateral Sclerosis (Als -Lou Gehrig's Disease) by Ecological Formulas This product, from Ecological Formulas, is an extract of bovine myelin sheath and is a rich source of myelin protective proteins. Use of this product may benefit those with myelin diseases such as multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS -Lou Gehrig's Disease) | |
 |
The Man Who Learned to Fall Directed By: Garry Beitel Also With: Garry Beitel and Barry Lazar (Producer) The Man Who Learned to Fall is a feature documentary about a gifted writer and sought after teacher who celebrates the wonder of life even as he is slowly dying of a fatal neuromuscular condition. At the age of 35, Philip Simmons learned that he had ALS or Lou Gehrigs disease. Married, with two young children and a promising career as an English Professor and writer, he was told that he had less than five years to live. Filmed in the foothills of the White Mountains of New Hampshire, this intimate portrait of Phil and his family captures the witty eloquence and poetic grace of a dying man and his heroic journey. As his muscles deteriorate and his body becomes increasingly paralyzed, Philip Simmons continues to wrestle joy from heartbreak, again and again and again, at each stage of his... |
 |
Body & Soul Also With: Warner Bros. (Producer) |
 |
ALS Awareness Key Chain, Oregon & SW Washington Chapter by Abernook Show support and spread ALS awareness with the swarovski crystal and bali silver keychain. This bracelet is designed using Swarovski crystals and Bali silver. Spouses, family and friends can now show their support and spread knowledge and awareness about the disease. A portion of the proceeds is being given to the ALS Association. Also available, ALS Bracelet, Earrings and Purse Charm |
 |
ALS Awareness Loop, ALSA New Mexico Chapter by Abernook This mini bracelet was designed to adorn wheelchairs, rear view mirrors, back packs and purses (as a purse charm). Now you can show your support any time. Made with Swarovski Crystals, Bali Silver along with a silver awareness charm. A portion of the proceeds is being donated to the ALS Chapters. |
 |
ALS Awareness Earrings, Oregon & SW Washington Chapter by Abernook Made with Swarovski Crystals and Bali Silver, you can now show your support through these ALS earrings. A portion of the proceeds goes to the ALS Association to provide aid in research, patient care, family care and support. Also available ALS bracelet and Purse Charm |
 |
Amyotrophic Lateral Sclerosis, Second Edition by Robert H. Brown Jr. (Editor), Michael Swash (Editor), Piera Pasinelli (Editor) Amyotrophic lateral sclerosis or motor neurone disease is one of the most debilitating and devastating of the neurological diseases. The only comprehensive textbook available on the topic, this completely reorganized and expanded new edition examines all aspects of ALS from pathology to patient care and provides the reader with a ready reference to help with the difficulties encountered in patient diagnosis and treatment. Undoubtedly an important work in the field, this book will be of great interest to clinical neurologists and trainees, and to all those concerned with the care of people with ALS. |
| © 2009 BrightSurf.com |